Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-16 Sale | 2023-08-18 4:03 pm | Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer | 311,297 | $8.25 | $2,568,200 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-11 Option Award | 2023-09-13 4:01 pm | N/A 2033-09-10 | Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer | 272,000 | $7.57 | 272,000 (Direct) | View |
| 2023-08-16 Exercise | 2023-08-18 4:03 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer | 311,297 | $3.72 | 0 (Direct) | View |
| 2023-08-16 Exercise | 2023-08-18 4:03 pm | N/A 2029-09-16 | Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer | 311,297 | $0 | 0 (Direct) | View |
| 2023-08-17 Gift | 2023-08-18 4:03 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 63,000 | $0 | 511,704 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 8:15 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | PARSHALL B LYNNE Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 8:14 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | Lynch Thomas J. Jr. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 8:14 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 8:13 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 8:13 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | Biller Scott Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 8:12 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 8:11 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 8:10 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-05-26 Gift | 2023-05-31 9:22 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 300,000 | $0 | 448,704 (Indirect) | View |
| 2022-02-10 Gift | 2023-02-22 4:23 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 127,850 | $0 | 890,324 (Direct) | View |
| 2022-10-25 Other | 2023-02-22 4:23 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 189,310 | $0 | 890,324 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 5:04 pm | N/A 2033-01-25 | Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 5:04 pm | N/A 2033-01-25 | Foghorn Therapeutics Inc. | FHTX | Cavalie Fanny Chief Strategy/Bus Ops Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 5:03 pm | N/A 2033-01-25 | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 5:03 pm | N/A 2033-01-25 | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 5:03 pm | N/A 2033-01-25 | Foghorn Therapeutics Inc. | FHTX | LaCascia Michael Chief Legal Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 5:02 pm | N/A 2033-01-25 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 280,000 | $0 | 280,000 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 5:02 pm | N/A 2033-01-25 | Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-10-27 Option Award | 2022-10-31 4:04 pm | N/A 2032-10-26 | Foghorn Therapeutics Inc. | FHTX | Lynch Thomas J. Jr. Director | 32,000 | $8.23 | 32,000 (Direct) | View |
| 2022-09-16 Exercise | 2022-09-19 4:06 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 40,000 | $0.54 | 930,629 (Direct) | View |
| 2022-09-16 Exercise | 2022-09-19 4:06 pm | N/A 2027-05-29 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 40,000 | $0 | 930,629 (Direct) | View |
| 2022-09-13 Gift | 2022-09-14 8:59 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director | 47,939 | $0 | 141,249 (Direct) | View |
| 2022-09-12 Exercise | 2022-09-14 8:59 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director | 82,000 | $0.73 | 141,249 (Direct) | View |
| 2022-09-12 Exercise | 2022-09-14 8:59 pm | N/A 2027-11-01 | Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director | 82,000 | $0 | 141,249 (Direct) | View |
Ownership(A) | 2022-09-13 8:45 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director | 0 | $0 | 96,396 (Direct) | View |
Ownership(A) | 2022-09-09 7:38 pm | N/A 2032-01-25 | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 0 | $0 | 283,107 (Direct) | View |
Ownership(A) | 2022-09-09 7:38 pm | N/A 2032-01-25 | Foghorn Therapeutics Inc. | FHTX | Cavalie Fanny Chief Strategy/Bus Ops Officer | 0 | $0 | 250,169 (Direct) | View |
| 2022-08-16 Option Award | 2022-08-18 7:09 pm | N/A 2032-08-15 | Foghorn Therapeutics Inc. | FHTX | PARSHALL B LYNNE Director | 32,000 | $16.34 | 32,000 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 6:15 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 1,858 | $3.72 | 175,673 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 6:15 pm | N/A 2029-02-12 | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 1,858 | $0 | 175,673 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 9:06 pm | N/A 2032-07-31 | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2022-08-03 9:05 pm | N/A 2031-01-27 | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 0 | $0 | 250,169 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 9:00 pm | 2023-06-21 2032-06-20 | Foghorn Therapeutics Inc. | FHTX | Biller Scott Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 9:00 pm | 2023-06-21 2032-06-20 | Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 9:00 pm | 2023-06-21 2032-06-20 | Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 9:00 pm | 2023-06-21 2032-06-20 | Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director | 16,000 | $0 | 16,000 (Direct) | View |